These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 37804361)

  • 1. Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine.
    Kannampuzha S; Murali R; Gopalakrishnan AV; Mukherjee AG; Wanjari UR; Namachivayam A; George A; Dey A; Vellingiri B
    Med Oncol; 2023 Oct; 40(11):323. PubMed ID: 37804361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment.
    Zhuang C; Guan X; Ma H; Cong H; Zhang W; Miao Z
    Eur J Med Chem; 2019 Feb; 163():883-895. PubMed ID: 30580240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
    Nasiri H; Valedkarimi Z; Aghebati-Maleki L; Majidi J
    J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
    Bashraheel SS; Domling A; Goda SK
    Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel drug targets and therapeutic perspectives. Towards a precision medicine].
    Hanson J
    Rev Med Liege; 2020 May; 75(5-6):460-465. PubMed ID: 32496698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine.
    Wu X; Xing X; Dowlut D; Zeng Y; Liu J; Liu X
    J Proteomics; 2019 Jan; 191():68-79. PubMed ID: 29621648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery.
    Kaliyaperumal R; Ranganathan S; Krishnamoorthy M; Mohan VK; Balaraman S; Rajapandian G; Sathiyasundar R; Ravindran S
    Recent Adv Drug Deliv Formul; 2023; 17(4):264-285. PubMed ID: 37909435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted drug delivery for cancer therapy: the other side of antibodies.
    Firer MA; Gellerman G
    J Hematol Oncol; 2012 Nov; 5():70. PubMed ID: 23140144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer.
    Lu Y; Yang Y; Zhu G; Zeng H; Fan Y; Guo F; Xu D; Wang B; Chen D; Ge G
    Int J Biol Sci; 2023; 19(11):3360-3382. PubMed ID: 37496997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individualization of anticancer therapy; molecular targets of novel drugs in oncology].
    Regulska K; Stanisz B; Regulski M
    Postepy Hig Med Dosw (Online); 2012 Nov; 66():855-67. PubMed ID: 23175342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering.
    Joo JI; Choi M; Jang SH; Choi S; Park SM; Shin D; Cho KH
    Adv Mater; 2020 Sep; 32(35):e1906783. PubMed ID: 32253807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Drug Metabolism Properties of Novel Therapeutic Modalities.
    Rock BM; Foti RS
    Drug Metab Dispos; 2019 Oct; 47(10):1097-1099. PubMed ID: 31399505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in targeted therapeutic agents.
    Nicolaides NC; Sass PM; Grasso L
    Expert Opin Drug Discov; 2010 Nov; 5(11):1123-40. PubMed ID: 22827748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-Drug Conjugates: A Review on the Epitome of Targeted Anti- Cancer Therapy.
    Hasan M; Alam S; Poddar SK
    Curr Clin Pharmacol; 2018; 13(4):236-251. PubMed ID: 30073930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
    Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
    Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and Opportunities in Cancer Drug Resistance.
    Ward RA; Fawell S; Floc'h N; Flemington V; McKerrecher D; Smith PD
    Chem Rev; 2021 Mar; 121(6):3297-3351. PubMed ID: 32692162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADCs, as Novel Revolutionary Weapons for Providing a Step Forward in Targeted Therapy of Malignancies.
    Amani N; Dorkoosh FA; Mobedi H
    Curr Drug Deliv; 2020; 17(1):23-51. PubMed ID: 31755387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-targeted drugs and drug resistance--challenges and solutions.
    Shefet-Carasso L; Benhar I
    Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.